A video replay of the COVID-19: Navigating Forward Webinar Series session, “Mitigating Securities Litigation Risks in the COVID Era: Understanding the Latest Regulatory Guidance and Trends in Shareholder Class Actions, SEC Enforcement Proceedings,” is available.
Webinar Replay: Consumer Fraud and Consumer Product Safety Commission Issues in the Pandemic
A video replay of the COVID-19: Navigating Forward Webinar Series session, “Consumer Fraud and Consumer Product Safety Commission Issues in the Pandemic,” is available.
Webinar: Consumer Fraud and Consumer Product Safety Commission Issues in the Pandemic
Duane Morris will be hosting the webinar, “Consumer Fraud and Consumer Product Safety Commission Issues in the Pandemic,” on May 6, 2021, from 1:00 p.m. to 2:00 p.m. Eastern.
This session is part of the Duane Morris COVID-19: Navigating Forward Webinar Series. For more information and the registration link, please visit the firm website.
Webinar Replay: Lessons Learned from Recent Headlines and Court Rulings on Products Liability Cases Across Industries
A video replay of the COVID-19: Navigating Forward Webinar Series session, “Lessons Learned from Recent Headlines and Court Rulings on Products Liability Cases Across Industries,” is available.
Webinar: Lessons Learned from Recent Headlines and Court Rulings on Products Liability Cases Across Industries
Duane Morris will be hosting the webinar, “Lessons Learned from Recent Headlines and Court Rulings on Products Liability Cases Across Industries,” on April 22, 2021, from 1:00 p.m. to 2:00 p.m. Eastern.
This is the seventh session of the Duane Morris COVID-19: Navigating Forward Webinar Series. For more information and the registration link, please visit the firm website.
Webinar: Mitigating Securities Litigation Risks in the COVID Era: Understanding the Latest Regulatory Guidance and Trends in Shareholder Class Actions, SEC Enforcement Proceedings
Duane Morris will be hosting the webinar, “Mitigating Securities Litigation Risks in the COVID Era: Understanding the Latest Regulatory Guidance and Trends in Shareholder Class Actions, SEC Enforcement Proceedings,” on May 12, 2021, from 1:00 p.m. to 2:00 p.m. Eastern.
This is the sixth session of the Duane Morris COVID-19: Navigating Forward Webinar Series. For more information and the registration link, please visit the firm website.
SBA Updates Interim Regulatory Guidelines to Greatly Expand Accessibility of Paycheck Protection Program Loans to Gaming Businesses
On April 24, 2020, the casino industry received some much-needed good news from the Small Business Administration (SBA). Specifically, the SBA issued revised regulatory guidelines for the CARES Act’s Paycheck Protection Program (PPP) that now make PPP loans available to small gaming businesses previously precluded from the program because of restrictions on gambling-based revenue, but otherwise met the eligibility requirements.
To read the full text of this Duane Morris Alert, please visit the firm website.
FDA Takes Steps to Enhance Availability of Safe and Effective Face Masks
Over the past week, the U.S. Food & Drug Administration (FDA) has taken a number of steps to enable manufacturers and distributors of face masks to more efficiently make their products available to the marketplace. FDA has accomplished this by establishing criteria that would allow manufacturers to bypass normally required (and often time-consuming) regulatory review.
To read the full text of this Duane Morris Alert, please visit the firm website.
Small Business Administration Updates Interim Regulatory Guidelines to Help Certain Gaming Companies
On April 14, 2020, the Small Business Administration (SBA) issued revised interim regulatory guidelines for the Paycheck Protection Program (PPP). The revisions provide, in relevant part, that certain companies which derive revenues from legal gaming activities are eligible for PPP loans and are not automatically ineligible as previously thought pursuant to the interim regulatory guidelines released on April 2, 2020, and discussed in our previous Alert.
To read the full text of this Duane Morris Alert, please visit the firm website.
FDC Changes OTC Drug Review Process in Response to CARES Act
Most of the hundreds of pages comprising the CARES Act, signed into law on March 27, 2020, concern measures for directly counteracting COVID-19 and assisting those dealing with economic consequences of the pandemic. Yet tucked away in Subtitle F of the legislation are a number of provisions—now law—which streamline FDA’s over-the-counter (OTC) drug review process. These changes are likely to lower the regulatory burden of getting a product through the OTC drug review process and provide incentives of market exclusivity for companies who do.
To read the full text of this Duane Morris Alert, please visit the firm website.